Burnett-Bowie et al. investigated the efficacy and safety of the synthetic aromatase inhibitor anastrozole to treat hypogonadism in aging men. The study enrolled 88 men (60 years or older ...

We read with interest the article by Marie Lund and colleagues published in The Lancet Oncology investigating the association ...

Aromatase inhibitors (AIs) are becoming the hormonal ... efficacy and safety of initial adjuvant therapy with letrozole or anastrozole versus the previous standard of 5 years of adjuvant tamoxifen ...

Mauras et al. conducted a double-blind, randomized, placebo-controlled trial to determine whether estrogen suppression with the selective aromatase inhibitor anastrozole, administered to growth ...

In focusing on aromatase inhibitor therapy ... significant difference in cognitive tasks between placebo (n = 74) and anastrozole groups (n = 77) at 24 months NA N N [15] Letrozole users (n ...

Treatment with the aromatase inhibitor anastrozole decreased the rate of bone maturation and improved height outcomes in children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.